Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

High Court Petition Asks Justices: What's A 'Willful' Kickback? No Photo Available

Does a "willful" act under federal anti-kickback law require a defendant to know that the conduct violates the law? That's the questio... (more story)

Adderall Indictment Shows DOJ Focus On Telehealth Drugs No Photo Available

The arrest of two digital health executives accused of conspiring to illegally distribute Adderall online is a "shot across the bow" f... (more story)

The Rise Of Carveout Deals In Healthcare No Photo Available

More healthcare companies are turning to deals in which a buyer snaps up a specific product or service line from a seller instead of t... (more story)